HMB (beta-hydroxy beta-methylbutyrate) is a metabolite of leucine that shows promise for reducing muscle breakdown during caloric restriction
This can backfire by increasing cortisol, depleting energy reserves, and triggering compensatory hunger
This pricing model removes barriers to access and allows patients to focus on clinical outcomes rather than cost escalation
Efficacy and Safety of a Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Compared With its Components Given Alone: Results of a Phase 3, Open-Label, Randomised, 26-Week, Treat-to-Target Trial in Insulin-Naive Patients With Type 2 Diabetes
Not all GLP-1 support products are created equal
It is not the first-choice injectable for uncomplicated Type 2 diabetes anymore, and understanding this shift helps explain why the GLP-1 question comes up so often